Patents by Inventor Linn Hodneland NILSSON
Linn Hodneland NILSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230406941Abstract: Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: February 17, 2023Publication date: December 21, 2023Applicants: BERGEN TEKNOLOGIOVERFØRING AS, BERGENBIO ASAInventors: David Robert MICKLEM, Sergej KIPRIJANOV, James Bradley LORENS, Lavina AHMED, Linn Hodneland NILSSON, Tone SANDAL
-
Patent number: 11584796Abstract: Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: GrantFiled: December 19, 2018Date of Patent: February 21, 2023Assignees: BERGENBIO ASA, BERGEN TEKNOLOGIOVERFØRING ASInventors: David Robert Micklem, Sergej Kiprijanov, James Bradley Lorens, Lavina Ahmed, Linn Hodneland Nilsson, Tone Sandal
-
Publication number: 20220185897Abstract: Antibodies which specifically bind to the Axl protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: October 18, 2021Publication date: June 16, 2022Applicant: BerGenBio ASAInventors: David Robert Micklem, Sergej Kiprijanov, Linn Hodneland Nilsson, Lavina Ahmed, Hallvard Haugen
-
Patent number: 11186643Abstract: Antibodies which specifically bind to the Axl protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: GrantFiled: April 20, 2018Date of Patent: November 30, 2021Assignee: BerGenBio ASAInventors: David Robert Micklem, Sergej Kiprijanov, Linn Hodneland Nilsson, Lavina Ahmed, Hallvard Haugen
-
Patent number: 11035008Abstract: The use of PHGDH as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of PHGDH modulators to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring PHGDH expression and/or activity.Type: GrantFiled: July 8, 2016Date of Patent: June 15, 2021Assignee: BerGenBio ASAInventors: Monica Hellesoy, Linn Hodneland Nilsson, David Robert Micklem
-
Publication number: 20190177419Abstract: Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: December 19, 2018Publication date: June 13, 2019Applicants: BERGEN TEKNOLOGIOVERFORING AS, BERGENBIO ASAInventors: David Robert MICKLEM, Sergej KIPRIJANOV, James Bradley LORENS, Lavina AHMED, Linn Hodneland NILSSON, Tone SANDAL
-
Patent number: 10208121Abstract: Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: GrantFiled: December 18, 2015Date of Patent: February 19, 2019Assignees: BERGEN TEKNOLOGIOVERFORING AS, BERGEBIO ASAInventors: David Robert Micklem, Sergej Kiprijanov, James Bradley Lorens, Lavina Ahmed, Linn Hodneland Nilsson, Tone Sandal
-
Publication number: 20180371096Abstract: Antibodies which specifically bind to the Axl protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: April 20, 2018Publication date: December 27, 2018Applicant: BerGenBio ASAInventors: David Robert MICKLEM, Sergej KIPRIJANOV, Linn Hodneland NILSSON, Lavina AHMED, Hallvard HAUGEN
-
Publication number: 20180208989Abstract: The use of PHGDH as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of PHGDH modulators to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring PHGDH expression and/or activity.Type: ApplicationFiled: July 8, 2016Publication date: July 26, 2018Applicant: BERGENBIO ASAInventors: Monica HELLESOY, Linn Hodneland NILSSON, David Robert MICKLEM
-
Patent number: 9975954Abstract: Antibodies characterized by their variable sequences/CDRs which specifically bind to the Axl protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: GrantFiled: June 18, 2015Date of Patent: May 22, 2018Assignee: BerGenBio ASAInventors: David Robert Micklem, Sergej Kiprijanov, Linn Hodneland Nilsson, Lavina Ahmed, Hallvard Haugen
-
Patent number: 9975953Abstract: Antibodies which specifically bind to the Ax I protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: GrantFiled: June 18, 2015Date of Patent: May 22, 2018Assignee: BerGenBio ASAInventors: David Robert Micklem, Sergej Kiprijanov, Linn Hodneland Nilsson, Lavina Ahmed, Hallvard Haugen
-
Publication number: 20170349658Abstract: Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: December 18, 2015Publication date: December 7, 2017Applicants: BERGEN TEKNOLOGIOVERFORING AS, BERGENBIO ASInventors: David Robert MICKLEM, Sergej KIPRIJANOV, James Bradley LORENS, Lavina AHMED, Linn Hodneland NILSSON, Tone SANDAL
-
Publication number: 20170314077Abstract: The use of Slfn11 as a biomarker for detecting the occurrence of epithlial-to-mesenchymal transition (EMT) in a subject, and the use of Slfn11 modulators to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Slfn11 expression and/or activity.Type: ApplicationFiled: November 13, 2015Publication date: November 2, 2017Applicant: BERGENBIO ASInventors: David Robert MICKLEM, Monica HELLESOY, Linn Hodneland NILSSON
-
Publication number: 20170129957Abstract: Antibodies characterized by their variable sequences/CDRs which specifically bind to the Axl protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: June 18, 2015Publication date: May 11, 2017Applicant: BERGENBIO ASInventors: David Robert MICKLEM, Sergej KIPRIJANOV, Linn Hodneland NILSSON, Lavina AHMED, Hallvard HAUGEN
-
Publication number: 20170107290Abstract: Antibodies which specifically bind to the Ax I protein are described. Also disclosed are methods for the production and use of the anti-Axl antibodies.Type: ApplicationFiled: June 18, 2015Publication date: April 20, 2017Applicant: BERGENBIO ASInventors: David Robert MICKLEM, Sergej KIPRIJANOV, Linn Hodneland NILSSON, Lavina AHMED, Hallvard HAUGEN